HealthStream (HSTM) Rating Reiterated by Cantor Fitzgerald

HealthStream (NASDAQ:HSTM)‘s stock had its “hold” rating reaffirmed by equities research analysts at Cantor Fitzgerald in a research report issued to clients and investors on Monday. They currently have a $24.00 price objective on the technology company’s stock. Cantor Fitzgerald’s target price suggests a potential upside of 7.96% from the company’s current price.

The analysts wrote, “On February 12, HSTM announced the sale of its patient experience business to Press Ganey Associates (private) for $65.5 million in cash. The patient experience business represented about 15% of total HSTM revenue.””

Several other research firms also recently issued reports on HSTM. ValuEngine downgraded HealthStream from a “hold” rating to a “sell” rating in a research note on Monday, February 5th. Robert W. Baird decreased their price objective on HealthStream from $30.00 to $28.00 and set an “outperform” rating for the company in a report on Wednesday, October 25th. Zacks Investment Research upgraded HealthStream from a “hold” rating to a “strong-buy” rating and set a $27.00 price objective for the company in a report on Wednesday, October 25th. Canaccord Genuity restated a “hold” rating and issued a $25.00 price objective on shares of HealthStream in a report on Monday, October 23rd. Finally, BidaskClub cut HealthStream from a “hold” rating to a “sell” rating in a report on Wednesday, January 31st. One analyst has rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $24.83.

HealthStream (NASDAQ HSTM) traded down $0.23 on Monday, hitting $22.23. The company’s stock had a trading volume of 107,251 shares, compared to its average volume of 94,778. HealthStream has a 1 year low of $21.15 and a 1 year high of $31.53. The firm has a market cap of $708.74, a P/E ratio of 123.50, a price-to-earnings-growth ratio of 4.74 and a beta of 0.90.

Several hedge funds and other institutional investors have recently made changes to their positions in HSTM. UBS Asset Management Americas Inc. bought a new position in shares of HealthStream in the 2nd quarter valued at about $205,000. Teacher Retirement System of Texas bought a new position in shares of HealthStream in the 4th quarter valued at about $215,000. Municipal Employees Retirement System of Michigan grew its holdings in shares of HealthStream by 59.5% in the 3rd quarter. Municipal Employees Retirement System of Michigan now owns 9,570 shares of the technology company’s stock valued at $224,000 after acquiring an additional 3,570 shares in the last quarter. GSA Capital Partners LLP bought a new position in shares of HealthStream in the 3rd quarter valued at about $237,000. Finally, Virginia Retirement Systems ET AL bought a new position in shares of HealthStream in the 3rd quarter valued at about $264,000. Institutional investors own 73.99% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was first reported by American Banking News and is owned by of American Banking News. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.americanbankingnews.com/2018/02/12/healthstream-hstm-rating-reiterated-by-cantor-fitzgerald.html.

HealthStream Company Profile

HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.

Analyst Recommendations for HealthStream (NASDAQ:HSTM)

Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply